TOP NEWS HIV drug designed to target resistant strains passes late-stage trial A promising Human Immuno-deficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS) drug has succeeded in a late-stage trial - paving the way to a low intensity treatment that could target drug-resistant strains. Editor